Worldwide, over 239.1 million cases of SARS-CoV-2 infection

According to statistics site worldometers.info, as of 10pm on October 12, the world recorded 239,177,209 cases of SARS-CoV-2, of which 4.875,901 deaths. The number of recovered patients has now reached 216,424,254 people.

An ambulance transports COVID-19 patients to a hospital in Kommunarka in Moscow, Russia. Photo: AFP
An ambulance transports COVID-19 patients to a hospital in Kommunarka in Moscow, Russia. Photo: AFP

Asia is the region most severely affected by the COVID-19 epidemic with 77.29 million infections, followed by Europe with 60.62 million infections. North America recorded 54.47 million cases, South America 38.04 million cases, followed by Africa 8.46 million cases and Oceania 260,529 infections.

In Europe, Russia recorded an additional 973 deaths, the highest number since the pandemic began in the country, and 28,190 new infections, bringing the total number of infected people since the beginning of the pandemic to about 7.8 million people. Due to the increase in the incidence of the disease, many localities in Russia have tightened restrictions. In addition, the Russian government is accelerating the vaccination schedule to avoid the risk of infection and the risk of serious illness.

In Italy, a law requiring all workers to present a "COVID-19 green card" upon arrival at work is about to take effect from October 15, to encourage people to get vaccinated against COVID-19. However, data released by the Italian Government's COVID-19 pandemic prevention official's office on October 11 showed that in the week to October 8, only about 410,000 people had been vaccinated. first COVID-19 vaccine, down 36% from the previous week and the lowest weekly figure since early July.

The bill initially appeared to encourage more people to get vaccinated, up 11% in the first week after September 16. In the following week from September 24 to October 1, the number of people getting injections also increased by 15%, but then dropped sharply in the week to October 8. Meanwhile, employers in northern Italy's industrial region have warned they will face labor shortages, and the heads of several regional governments have said they will not be able to provide enough tests for patients. workers who refuse to be vaccinated. In addition, the above regulation met with opposition from a part of employees.

Treating patients infected with COVID-19 in Bangkok, Thailand. Photo: AFP
Treating patients infected with COVID-19 in Bangkok, Thailand. Photo: AFP

In Asia, many countries continue to record more cases and deaths from COVID-19, such as Laos with 549 cases and 3 deaths; Thailand 9,445 cases and 84 deaths; Philippines 8,615 cases and 236 deaths... while Cambodia and Japan are making efforts to promote booster dose of vaccine.

Specifically, Cambodia has launched a nationwide campaign to boost vaccination against COVID-19 vaccine, in the context that the vaccination campaign for 10 million adults in the country has been completed over 99%. This Southeast Asian country recorded 267 new cases and 17 deaths, bringing the total number of cases to 115,335 cases and 2,544 deaths. Thus, October 12 is the 11th day the number of new COVID-19 cases in Cambodia fluctuates around 200 cases/day, much lower than the level of over 800 cases/day at the end of September. Cambodia's socio-economic reopening is more and more favorable, Phnom Penh Mayor Khuong Sreng still warned people to be more cautious to prevent the spread of COVID-19 and to move towards opening all areas. as soon as possible.

In Japan, Prime Minister Kishida Fumio's government is promoting steps to be able to deploy booster doses of the vaccine as soon as December. Previously, during a meeting on September 17, the Vaccine Council and prophylactic vaccination under the Japanese Ministry of Health, Labor and Welfare (MHLW) also emphasize the need for additional shots as the immunity of the vaccinated person decreases over time. MHLW also advocates deploying booster shots for health care workers who received the first dose from February and will start administering injections for the elderly from the beginning of 2022.

Health workers give people a COVID-19 vaccine in Banda Aceh, Indonesia. Photo: AFP
Health workers give people a COVID-19 vaccine in Banda Aceh, Indonesia. Photo: AFP

Meanwhile, Indonesia announced that it will complete the COVID-19 vaccination for the elderly before the upcoming Christmas and New Year holidays to prevent the risk of outbreaks after religious events and long holidays. . President Joko Widodo also directed the Christmas and New Year's preparation strategy, noting the relevant ministries to raise their vigilance amid the sharp decline in the number of COVID-19 cases.

In South Korea, a number of traditional markets in the capital Seoul - familiar destinations for domestic and foreign tourists - have recently become "hot spots" for new infections, especially in the context that the country is preparing implemented a plan to "live with COVID-19" despite the 4th wave of infections showing no signs of cooling down.

Specifically, four famous traditional markets in the Seoul metropolitan area have all been linked to major disease outbreaks since July, the time when the fourth wave of infections broke out in the country. These are Garak market in Songpa district (south of Seoul), Cheongnyangni market in Dongdaemun district, Jungbu market in central Seoul and Mapo Agricultural - Seafood market (in Mapo district). According to the Korea Centers for Disease Control and Prevention (KDCA), the number of COVID-19 cases linked to traditional markets may continue to soar after epidemiological investigations are over. The initial cause given by the Korean health agency was from epidemic prevention, including poor management of visitors' entry and exit logs.

India has recommended urgent use of the COVID-19 vaccine produced by Bharat Biotech in the country for children under 12 years old. With this move, Bharat Biotech became the first company in India to be approved for a vaccine for children after reviewing the trial data of this vaccine in the 2-18 age group. The recommendation comes as India has shifted its focus to vaccinating children against COVID-19, after having given more than 950 million doses to adults in the country of 1.4 million people.

Johnson & Johnson pharmaceutical company's COVID-19 vaccine. Photo: AFP
Johnson & Johnson pharmaceutical company's COVID-19 vaccine. Photo: AFP

Regarding the booster dose of the vaccine, the US pharmaceutical companies Moderna and Johnson & Johnson (J&J) on October 12 both announced their booster dose data in the context of the regulatory agency's advisory committee. The US Food and Drug Administration (FDA) will meet on October 13-14 to discuss this issue.

Moderna believes that the FDA should authorize the use of a booster dose of its vaccine for older adults and people at high risk of infection who have received two full doses. According to Moderna, the booster dose of its vaccine supports public health by restoring the immune response, while reducing the number of infections in adults who have completed immunization. Meanwhile, J&J also published data showing that its ability to prevent COVID-19 is increased after a booster dose of its vaccine. According to J&J, the booster dose can be given 2 months after the injection of its vaccine (1 dose).

Google Tech News

Post a Comment

Previous Post Next Post